Potentiating Cancer Vaccination by Adjuvant-Loaded Cryo-Shocked Tumor Cells.

Mo Chen,Huangjuan Li,Jing Zang,Yueyang Deng,Hongjun Li,Qing Wu,Tianyuan Ci,Zhen Gu

DOI: https://doi.org/10.1016/j.biomaterials.2023.122319

IF: 14

2023-01-01

Biomaterials

Abstract:Cancer vaccine holds vast promise in potentiating tumor immunotherapy. Here, we developed a simple cancer vaccine based on the liquid nitrogen-treated cells (LNT cells) that engineered by one-shot shocking of the live tumor cells in liquid nitrogen. In this vaccine, the obtained LNT cells served as both tumor antigens and delivery vehicles to load the adjuvant imiquimod (R837). This design could achieve efficient co-uptake of antigen/adjuvant by antigen presenting cells (APCs) and prolong in vivo retention of tumor antigens and adjuvants. This adjuvant-loaded LNT cells augmented in vivo antitumor responses and enhanced survival in melanoma-bearing mouse model compared with conventional whole-cell vaccine of the mixture of tumor lysis and adjuvant.